Antiviral treatment could not provide clinical benefit in management of mild COVID-19: A Retrospective Experience from Field hospital

Antiviral treatment could not provide clinical benefit in management of mild COVID-19: A Retrospective Experience from Field hospital

Background: Coronavirus disease 2019 (COVID-19) has affected over 145 million infected people and 3 million deaths worldwide. There has been limited data to recommend either for or against use of antiviral regimens in mild COVID-19 patients. This study aimed to compare clinical outcomes between mild...

Full description

Bibliographic Details
Main Authors: Natsuda Aumpan, Ratha-korn Vilaichone, Sarita Ratana-Amornpin, Surat Teerakapibal, Pisanu Toochinda, Gasinee Witoonchart, Surapon Nitikraipot
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Journal of Infection and Public Health
Subjects:
COVID-19
Lopinavir-ritonavir
Darunavir-ritonavir
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034121002161

Similar Items

Similar Items